Prevalence rates of End-Stage Kidney Failure (ESKF) have risen in across the world in recent years, making it one of the most common chronic illnesses. The main treatment for ESKF is haemodialysis, where one is ‘connected’ to a dialysis machine to clean and filter the blood via a surgically-created portal, also known as ‘vascular access’. Without functioning vascular access, dialysis is impossible. People with ESKF have different experiences with their access modalities, but universally describe their access point as a ‘lifeline’.